Androgen Receptor Knockdown Enhances Prostate Cancer Chemosensitivity by Down-Regulating FEN1 through the ERK/ELK1 Signaling Pathway

Researchers demonstrated that androgen receptor knockdown improved the docetaxel sensitivity of prostate cancer cells by downregulating flap endonuclease 1 (FEN1) through the ERK/ELK1 signaling pathway.